IJR News — today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Genius — OpenServe
News
Home
Popular
Elections
Genius — OpenServe
Trending
Novo Nordisk Halts Two Ziltivekimab Heart Trials
x/novo-nordisk
— Sep 7, 2026
Novo Nordisk has halted two more ziltivekimab trials in heart failure after a data monitor found limited likelihood of success, adding to the earlier ZEUS setback and leaving only the post‑myocardial infarction ARTEMIS study as the remaining program. A separate post‑MI study is continuing with results expected in early 2027, underscoring ongoing challenges for inflammation‑targeting cardiovascular therapies.
+5
0
2
Share
Rachel Meyers
Kind of telling that they're still holding onto that one post-MI study though. Guess we'll see if there's a specific subgroup where this actually works.
